Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2003
05/21/2003EP1311295A2 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
05/21/2003EP1311292A2 Vitronectin receptor antagonist pharmaceuticals
05/21/2003EP1023268B1 Isoquinolines as urokinase inhibitors
05/21/2003EP0997461B1 Processes for the preparation of pyridine derivatives
05/21/2003EP0874827B1 Quinoline derivatives as nk3 antagonists
05/21/2003EP0851855B9 Acylated derivatives of melatonin and its analogues, useful as medicaments
05/21/2003CN1419552A 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors
05/21/2003CN1419548A 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
05/21/2003CN1419546A 4,5-dihydro-1h-pyrazole derivatives having cbi-antagonistic activity
05/21/2003CN1419545A 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
05/21/2003CN1419542A Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides 403
05/21/2003CN1419541A Pharmaceutically active pyrrolidine derivatives as BAX inhibitors
05/21/2003CN1419537A Insecticidal anthranilamides
05/21/2003CN1419452A Synergistic methods and compositions for treating cancer
05/21/2003CN1418882A Substituted sulfonic N-[(amino imino methyl) phenyl alkyl]-acacycloamide compound
05/21/2003CN1418879A Process for preparing 8-methoxy-quinolone
05/21/2003CN1418872A 1,4-pentadiene-3-ketone compound containing halogenoindyl, and method for preparing same and medicinal use thereof
05/21/2003CN1109032C Compounds analogous to thalidomide from class comprising pipeidine-2,6-diones
05/21/2003CN1109022C Arylalkanoyl pyridazines derivatives, its preparation method, medicine comprising samd and use thereof
05/21/2003CN1108797C Quinazolinone pharmaceuticals and use thereof
05/20/2003US6566528 Reacting 2-chloro-3-chloromethyl-5-methyl pyridine and 2-nitroimino-1,3-diazacyclopentane in the presence of a base and an organic solvent; insecticides that act at the nicotinic acetylcholine receptor
05/20/2003US6566526 Intermediates useful for the preparation of antihistaminic piperidine derivatives
05/20/2003US6566518 Trifluoromethylpyri(mi)dine carboxamides
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566383 Sulfonyltriazol derivatives and their use for combating micro-organisms
05/20/2003US6566379 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
05/20/2003US6566377 Have utility as, inter alia, hypoglycemic, and anti-obesity agents.
05/20/2003US6566376 Diphenyl-piperidine derivative
05/20/2003US6566372 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer
05/20/2003US6566370 Administering decahydroisoquinoline-3-carboxylic acid derivative for therapy of migraine
05/20/2003US6566364 Linear or cyclic ureas
05/20/2003US6566359 For use as platelet- activating factor antagonists, inhibitors of certain protein kinases, transcriptional inhibitors of COX-2(cyclooxygenase-2) expression, and as agents in protecting brain tissue from injuries related to trauma
05/20/2003US6566356 3-amido or 3-sulfonylamino azetidine compounds and their preparation; high affinity for cannabinoid receptor CB1 type, useful in treating central nervous system, immune, gastrointestinal or cardiovascular disorders, drug abuse
05/20/2003US6566118 Generation of recombinant adeno- associated virus particles; generate nutrient broth, inoculate with genetically engineered cells, propagate cells and vector, release vector, harvest viral particles
05/20/2003US6565828 Bifunctional chelant for attaching diagnostic metals and therpeutic isotopes to target specific biomolecules; heavy metal detoxification
05/20/2003CA2281244C Process for preparing trovafloxacin acid salts
05/20/2003CA2234239C Indole carbamates as leukotriene antagonists
05/20/2003CA2223016C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
05/20/2003CA2144962C 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistant cancer cell sensitizers
05/15/2003WO2003040257A1 Electroluminescent platinum compounds and devices made with such compounds
05/15/2003WO2003040256A2 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
05/15/2003WO2003040147A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease__________________________________________________________________________________________________________________________
05/15/2003WO2003040140A1 Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo(5,6)-cyclohepta-(1,2b)-pyridin-11-ylidene)-1-piperidinecarboxyli c acid ethyl ester (loratadine)
05/15/2003WO2003040131A1 Aminopyrimidines and pyridines
05/15/2003WO2003040130A1 $g(D)1-PYRROLINES
05/15/2003WO2003040129A1 Halogenated nitrobutadienes for controlling animal pests
05/15/2003WO2003040128A1 Pyridine derivatives as nmda receptor ligands
05/15/2003WO2003040110A1 Triazole derivatives as cyclooxygenase (cox) inhibitors
05/15/2003WO2003040109A2 Quinazoline derivatives as antitumor agents
05/15/2003WO2003040108A1 Quinazoline derivatives as antitumor agents
05/15/2003WO2003040107A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
05/15/2003WO2003040106A1 Preparation and use of substituted imidazoles
05/15/2003WO2003040098A1 Novel metalloproteinase inhibitors
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003039546A1 New uses for anti-malarial therapeutic agents
05/15/2003WO2003039488A2 A method for treating inflammatory bowel disease
05/15/2003WO2003039460A2 Mitotic kinesin inhibitors
05/15/2003WO2003039440A2 Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
05/15/2003WO2003031435A8 Pyrazole derivatives as glycine transporter inhibitors
05/15/2003WO2003000692A3 Oxytocin agonists
05/15/2003WO2002004423A9 Thrombin inhibitors comprising an aminoisoquinoline group
05/15/2003US20030092915 Using phase transfer catalyst and quaternary ammonium compound
05/15/2003US20030092914 Process for preparing alkanesulfonyl pyridines
05/15/2003US20030092913 Tinuvin p-hindred amine light stabilizer and derivatives thereof
05/15/2003US20030092912 Brain disorders, anticonvulsants, antidepressants, drug abruse
05/15/2003US20030092756 Antiproliferative agents
05/15/2003US20030092751 3-glyoxlylamideindoles for treating cancer
05/15/2003US20030092749 Kinase inhibitors; antiinflammatory agents; osteoporosis; anticancer agents
05/15/2003US20030092744 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
05/15/2003US20030092740 Anticoagulants
05/15/2003US20030092739 Pesticides
05/15/2003US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases
05/15/2003US20030092727 Hydroxamic and carboxylic acid derivatives
05/15/2003US20030092726 Antitumor, anticancer agents
05/15/2003US20030092722 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolines useful as HIV reverse transcriptase inhibitors
05/15/2003US20030092721 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092718 4-amino-2-(2-pyridyl)pyrimidines as microbicidal active substances
05/15/2003US20030092717 Inhibitors of p38 kinase
05/15/2003US20030092714 Heterocyclic inhibitors of ERK2 and uses thereof
05/15/2003US20030092712 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092709 6-Methylnicotinamide derivatives as antiviral agents
05/15/2003US20030092705 Reverse malaria drug resistance
05/15/2003US20030092702 Antiinflammatory agents; autoimmune disease; autoimmune diseases
05/15/2003US20030092698 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa
05/15/2003US20030092694 Central nervous system disorders; side effect reduction
05/15/2003US20030092679 Novel non-convalent thrombin inhibitors
05/15/2003US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
05/15/2003US20030092677 Glutamate receptor antagonists
05/15/2003CA2466375A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2466143A1 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
05/15/2003CA2466119A1 Electroluminescent platinum compounds and devices made with such compounds
05/15/2003CA2466066A1 .delta.1-pyrrolines
05/15/2003CA2465948A1 A method for treating inflammatory bowel disease
05/15/2003CA2465711A1 Aminopyrimidines and pyridines
05/15/2003CA2465491A1 Mitotic kinesin inhibitors
05/15/2003CA2465100A1 Quinazoline derivatives as antitumor agents
05/15/2003CA2465068A1 Quinazoline derivatives as antitumor agents
05/15/2003CA2459745A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
05/14/2003EP1310497A1 Pyrazole derivatives, pest controllers containing the same as the active ingredient and process for their production
1 ... 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 ... 1080